#case studies of medical breakthroughs

[champstorymedia]

Innovations in Hospital Care: A Look at the Cutting-Edge Technologies Shaping the Industry

Introduction In today’s rapidly advancing healthcare landscape, hospitals are continuously seeking ways to improve patient care, increase efficiency, and enhance outcomes through the integration of cutting-edge technologies. From telemedicine solutions to artificial intelligence, the innovations in hospital care are revolutionizing the way healthcare is delivered. Let’s delve into some of the…

[reasonsforhope]

A new treatment combining ReCET and semaglutide could eliminate the need for insulin in type 2 diabetes, with 86% of participants in a study no longer requiring insulin therapy. The treatment was safe and well-tolerated, and further trials are planned to confirm these results.

Groundbreaking research presented at UEG Week 2024 introduces a promising new treatment approach for type 2 diabetes (T2D) that has the potential to greatly reduce or even eliminate the need for insulin therapy.

This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of insulin therapy for 86% of patients.

Globally, T2D affects 422 million people... While insulin therapy is commonly used to manage blood sugar levels in T2D patients, it can result in side effects... and further complicate diabetes management. [Note: Also very importantly it's fucking bankrupting people who need it!!] A need therefore exists for alternative treatment strategies.

Study Design and Outcomes

The first-in-human study included 14 participants aged 28 to 75 years, with body mass indices ranging from 24 to 40 kg/m². Each participant underwent the ReCET procedure under deep sedation, a treatment intended to improve the body’s sensitivity to its own insulin. Following the procedure, participants adhered to a two-week isocaloric liquid diet, after which semaglutide was gradually titrated up to 1mg/week.

Remarkably, at the 6- and 12-month follow-up, 86% of participants (12 out of 14) no longer required insulin therapy, and this success continued through the 24-month follow-up. In these cases, all patients maintained glycaemic control, with HbA1c levels remaining below 7.5%.

Tolerability and Safety

The maximum dose of semaglutide was well-tolerated by 93% of participants, one individual could not increase to the maximum dose due to nausea. All patients successfully completed the ReCET procedure, and no serious adverse effects were reported.

Dr Celine Busch, lead author of the study, commented, “These findings are very encouraging, suggesting that ReCET is a safe and feasible procedure that, when combined with semaglutide, can effectively eliminate the need for insulin therapy.”

“Unlike drug therapy, which requires daily medication adherence, ReCET is compliance-free [meaning: you don't have to take it every day], addressing the critical issue of ongoing patient adherence in the management of T2D. In addition, the treatment is disease-modifying: it improves the patient’s sensitivity to their own (endogenous) insulin, tackling the root cause of the disease, as opposed to currently available drug therapies, that are at best disease-controlling.”

Looking ahead, the researchers plan to conduct larger randomized controlled trials to further validate these findings. Dr. Busch added, “We are currently conducting the EMINENT-2 trial with the same inclusion and exclusion criteria and administration of semaglutide, but with either a sham procedure or ReCET. This study will also include mechanistic assessments to evaluate the underlying mechanism of ReCET.”

-via SciTechDaily, October 17, 2024

--

Note: If it works even half as well as suggested, this could free so many people from the burden of the ongoing ridiculous cost of insulin. Pharma companies that make insulin can go choke (hopefully).

[local-idiotic-texan]

UHHWISHEOEBEL SO.. UHM.. PEKELN UHMM OKAY I'LL DO THIS ANOTHER POST

Filler post for now though!! AHEM!! SITE-61 AND IT'S DEPARTMENTS ARE WEIRD:

Security Department - First Line of Defense. The On-Site Guard. The Security Force.

Class-D - The test subjects :3

Scientific Department - Your doctore. The fuckin NEEEEERRRRDDDDSSSS!!!

Medical Department - Your LITERAL Doctores. ALSO NERDS!!!!

Physiology Department - EW THERAPISTS

Mobile Task Force - The guys who do the same thing as Field Agents except they also fight in proxy wars against GoIs for The Foundation :3

Nine Tailed Fox - YOU NEVER WANNA HEAR THESE GUYS BE ACTIVE. SOMETHING WENT ABSOLUTELY WRONG IF YOU HEAR OR SEE THEM GET DEPLOYED. THEY GO INSIDE SITES. NOT OUT OF THEM. INTO THEM.

Foundation Personnel - Basically every single person. If you don't apply for a department, this is what you're in.

Field Crew - It's a department nobody's actually in forever. You get assigned to a temporary crew, and then either get the weapons to go hunt someone or something down (Field Agents) or are assigned something to study or capture that's put in the wild. (Field Researchers)

Janitorial Staff - Clean up the messes personnel and anomalies leave behind.

Custodial Staff - NEVER MISTAKE THEM FOR THE JANITORIAL CREW OR THEY WILL GIVE YOU MOP WATER. The people who work the mess halls, canteens, cafeterias, whatever you call them? They're the chefs behind it all. They're also in charge pf emergency rationing of water and food, providing anomalies with their meals, and more! :)

Internal Security Department - Site Directors, basically. Make sure things are running correctly.

The O5 Council - "but that's not a department!! 🥺" WRONG!!! IT'S THEIR REPRESENTATIVES! THEIR PERSONAL ADVISORS! THEIR SECRETARIES AND ASSISTANTS! HELL, EVEN THE RED RIGHT HAND IS PART OF THIS DEPARTMENT OF THE SAME NAME!

Board of Classification - One per Object Class. A group of people who determine which object gets what object class, why, and how to contain said object. Case. by. case.

Intelligence Agency - Spies, scouts, and bugs for The Foundation. Usually former theater kids.

Ethics Committee - Make sure morals aren't being broken. Surprisingly? Both the strongest and weakest department. Capable of overthrowing The Administrator if support for the cause is UNANIMOUS but also have to find a workaround to "FOR A SCIENCE!!"

Theology Department - Bunch of religious people. Study scripture. Build chapels into their locations, even when it's unauthorized.

Monitoring Committee - FUCKING SNITCHES. "The Ethics Committee is the worst!! 🙄" WRONG!! MONITORING COMMITTEE. FUCKING "O5's Eyes and Ears" IS THEIR NICKNAME THEY FUCKING SNITCH ALL THE GODDAMN TIME OHMYGOD I FUCKING HATE THEM ALL I HOPE THEY DIE

Paedology Committee - Started FROM Site-61, actually! Dedicated to Anomalous Children getting a fucking normal childhood, and a good education! Board of Education, basically. :)

Maintenance and Repair Crew - Makes sure Site Infrastructure is maintained.

Internal Technician Department - Screams because "my computer won't turn on ://" and it's just because you haven't charged it.

Library of Records - Look around in Foundation History to archive lost files, updates records and files ranging from minute details about a person's life to major breakthroughs in Foundation and GoI History!

Federal Administration - World Governments and Politics found out about 2012 :( LUCKILY!! Not that political in Site-61 (as a series). Most members ARE politicians or representatives of their local areas, but sometimes (like the characters who are part of this department in Site-61!!) They're just random civilians who got accepted into The Foundation AS "politicians" so now they're stuck in their offices making legislature or whatever.

Department of Public Affairs - The Public found out about 2012 :( LUCKILY!! This department exists! It's mostly full of retirement-aged people (60 - 80) who wanna still receive a paycheck so all they do in exchange is represent The Foundation out in public and approve of what the public can and cannot do with the information they have about certain anomalies

yeah :3

[secretlythepits]

Welcome to the World of Clinical Trials!

It’s a veritable casino where you bet the last good days of your life to hopefully get more. The odds are stacked against you, but you might be the lucky one! You might get the miracle! You almost certainly will not… but… but… winner takes all!

Door Number 1:

A blind randomized study with a promising drug. There is a 50/50 you won’t even get it. You will have to travel a 4 hour car ride every 2 weeks to get it. Or get nothing. Hopefully cancer charities can help ameliorate the costs of travel, but probably not 100%. Logistics for getting kids to and from school will be reliant on others.

Doors Numbers 2 and 3.

Honestly, you don’t completely understand them. They seem like midline therapies. Every 3 weeks. One has some similarities to a drug that didn’t work for you. Another is opposite. Maybe? You aren’t quite sure. There are side effects. They say they are only about 10% of chemo, but who knows? Again, all these are a 4 hour drive away.

Door Number 4

A vaccine for the virus that caused your cancer. It’s different than the one available to people younger than you. This is the first human trial. It will not attack the cancer, but maybe disable this virus that serves as the engine behind the cancer. You feel great now, so stable disease is attractive. However, this study is hard to get into and you can’t get a slot until the Feb. 17. How much will your cancer grow in the meantime? It’s 2 visits 28 days apart. Just a vaccine shot and wait around 6 hours to monitor. Again, 4 hours away.

Door Number 5

Is probably locked to you. It’s a monotherapy so if you are one of the 5-8% of the population that has this protein, you can get it. Did well in European trials, adding months and sometimes a year to life. Again, 4 hours away, but probably not even an option.

There is a possibility of doing one trial and then switching to another later. In some cases. But the truth is, your cancer is aggressive and time wasted in the wrong trial might be all the time you have.

Do you bet it all and hope you get the promising drug in Door 1, knowing you might not even get it? Lately, you have not been lucky. The schedule tethers your remaining life to this treatment in another city. It might not even work. It might mean bad side effects. Is the life it could extend going to even be worth it (meaning time to really live and enjoy life, not a couple extra months spent in treatment)? But, could this be the breakthrough drug that changes everything?

Winner takes all. Loser loses all.

*****

What I have learned by reading through endless medical publications is that what a lay person considers an amazing breakthrough is very different than what an oncologist does. As a regular jane, I am not impressed by 2 extra months. I also think those months might be miserable because cancer treatments usually are. 3 months of regular life is a lot better than 5 months of being in treatment. Doctors, on the other hand, are excited by anything that moves the needle. They think globally and see those two months as progress. They see the promise it is leading to, while we just see the individual life ending.

The research doctor called us after hours to give us a rundown of the studies. It was a surprise. He sent an email with descriptions for us to look over. Our real appointment with him is a Thursday zoom, but he wanted us to be informed. I so appreciate that, because it’s a lot more complicated than we thought. So many factors to consider.

These options, to blow on the dice and take a gamble, are a blessing. I think of those who already died who never had a chance. I also know that this is the way medicine moves forward. But they are also a burden. The stakes are so high.

The house always wins.

[hanro50]

The unremarkable biped #6

The biped's exact features have remained hidden till this stage due to the atmosphere on the station being uncomfortable for the biped. Medical checkups by the ship's medical wing have made breakthroughs in understanding the complex mechanisms that make up the creature's biological function.

While it has been known the biped requires high levels of oxygen to function, the creature also enjoys a slightly higher level of atmospheric pressure. Although further research has reduced the size of the atmospheric suite the creature requires considerable.

A detailed study of the creature's biological system has revealed some insight into the creature's native environment. It seems the creature's cells use a strange strand of molecules to encode instructions. Samples collected from the monster we recovered some time ago, and which the creature helped subdue, revealed that despite being different. Their biological processes operate similarly.

Perhaps bipedal life in the environment the creature evolved in only occurred once. Although this theory is "incorrect" according to the creature whom listed two other species. Although the translator device failed to decode what the creature was trying to convey.

Or I hope that is the case, I do not wish to meat the monstrosities the creature mentioned that could withstand flying an unshielded ship through the aftermath of a supernova explosion.

[nuadox]

US: Breast cancer deaths have decreased by 44% since 1989, despite an increase in cases

- By Nuadox Crew -

Breast cancer rates in the U.S. have been rising, particularly among younger women and Asian Americans, according to a study by the American Cancer Society.

From 2012 to 2021, breast cancer cases increased by 1% annually, with rates growing faster for women under 50 than those older. Asian American women saw the most rapid increase in incidence, possibly linked to immigration patterns. Despite this, the breast cancer death rate has declined by 44% since 1989, preventing over 517,900 deaths.

However, the benefits of medical advancements have been unevenly distributed. Black women have a 38% higher mortality rate than White women, despite having lower breast cancer incidence, due to systemic racism and less access to quality care. Native American mortality rates have remained unchanged since 1990. The report calls for more racial diversity in clinical trials and improved access to high-quality screening for underserved women.

In April, the U.S. Preventive Services Task Force recommended that women begin biennial breast cancer screenings starting at age 40, adjusting its previous guidance.

Read more at AFP/Medical Xpress

Scientific paper: Angela N. Giaquinto et al, Breast cancer statistics 2024, CA: A Cancer Journal for Clinicians (2024). DOI: 10.3322/caac.21863

--

Other recent news:

China's BeiDou-3 Navigation Satellite System: The final two satellites for China's independently-developed BeiDou-3 Navigation Satellite System were launched in September, completing the system. President Xi Jinping has been closely involved in the project, emphasizing its importance for China's economic and social development.

Step Aside, Bolts: Discover the future of stronger structural connections with interlocking metasurfaces.

Tech NL Innovation Week: The tech sector in Newfoundland and Labrador (Canada) has seen significant growth, now employing nearly 10,000 people. The industry recently gathered to celebrate achievements and discuss the future.

California Governor's Tech Bill Deliberations: Governor Gavin Newsom is carefully considering a high-profile bill aimed at regulating the tech industry, particularly AI companies. He recently vetoed the bill, citing concerns about stifling innovation.

Dark Matter and Mars' Mysterious Wobble: Scientists are exploring changes in Mars' orbit as a potential new way to study dark matter.

Methane Emissions from Dairy Farms: New research indicates that methane emissions from slurry stores on dairy farms could be significantly higher than previously thought.

Antarctic Krill Carbon Storage: Scientists have discovered that Antarctic krill store as much carbon as key coastal habitats like mangroves and salt marshes.

Weight Loss Habits: A study has identified two key habits linked to a lower BMI, offering new insights into weight management.

Linus Pauling's Electron Bonding Theory: A breakthrough study has validated the existence of a stable single-electron covalent bond between two atoms, confirming a century-old theory by Linus Pauling.

[foundationhq]

EMPLOYEE ID 6456-8217-8; 𝐶𝑂𝑊𝐵𝑂𝑌 𝐺𝑅𝐸𝐸𝑇𝐼𝑁𝐺.

𝐍𝐚𝐦𝐞 Seth Hiroshi Masters 𝐀𝐠𝐞 38 𝐆𝐞𝐧𝐝𝐞𝐫/𝐏𝐫𝐨𝐧𝐨𝐮𝐧𝐬 cis man, he/him  𝐅𝐚𝐜𝐞𝐜𝐥𝐚𝐢𝐦 Will Sharpe     𝐒𝐭𝐚𝐭𝐮𝐬 retired

PROFILE.

Unassuming and reserved, [𝐶𝑂𝑊𝐵𝑂𝑌 𝐺𝑅𝐸𝐸𝑇𝐼𝑁𝐺]’s record of service can, at best, be described as consistent. However, the origins of this operative’s connection to the Foundation are strikingly non-standard. As a child they survived not only direct exposure to an apocalyptic Apollyon-Class SCP that manifested at their hometown [DATA EXPUNGED], but also the contingency plan enacted to avoid a K-Class Scenario. Despite administration of Class B Amnestics to target [𝐶𝑂𝑊𝐵𝑂𝑌 𝐺𝑅𝐸𝐸𝑇𝐼𝑁𝐺]’s memories regarding the real reason that half the population of [DATA EXPUNGED] disappeared overnight, medical reports indicate the operative has persistent dreams involving the incident. So it was quite serendipitous that [𝐶𝑂𝑊𝐵𝑂𝑌 𝐺𝑅𝐸𝐸𝑇𝐼𝑁𝐺] ended up working for the Foundation in adulthood. Whether this result can be chalked up to coincidence or this operative’s connection to researcher [𝑇𝑅𝐸𝐸 𝐻𝑈𝐺𝐺𝐸𝑅] is yet to be seen. In any case, the Ethics Committee is certain that their participation in MTF Chi-00 will lead to a future breakthrough on synthetic amnestics, and will be supervising their growth within the team. — Internal Memo from the Ethics Committee.

LAST ASSIGNMENT.

JR.  RESEARCHER;  Site-169, Anomalous  Entity  Engagement  Division,  studying  behavioral  interventions  in  improving  anomaly  cooperation.  Former  site  evaluator,  worked  with  Rho-7,  Nu-3,  Delta-4,  and  Lambda-12. 

INTERRELATIONS OF NOTE.

𝑂𝐿𝐷 𝑆𝑃𝑂𝑅𝑇. In contrast to you, they seem able to remain calm under any sort of pressure. It’s admirable and comforting. But only kind of, because it’s hard not to compare yourself to them. Insecurities about whether or not you should be here are starting to spill over and taint the work you’re doing. Thankfully, it seems that 𝑂𝐿𝐷 𝑆𝑃𝑂𝑅𝑇 has noticed and has decided to watch over you. Or are they merely just watching?

𝑇𝑅𝐸𝐸 𝐻𝑈𝐺𝐺𝐸𝑅. You’d follow them to hell and back, but… you’re starting to think this latest venture might have been a mistake — for both of you. You’re hoping you’re wrong and it’s just stress over the new position. Plus, you can tell how excited 𝑇𝑅𝐸𝐸 𝐻𝑈𝐺𝐺𝐸𝑅 is by all this. But like with everything else, doubts have started to creep in and you’ve have always wondered if they really understand what the purpose of the Foundation is. Still, you’d never leave their side if you have any say about it.

𝐸𝐿𝐸𝑉𝐴𝑇𝑂𝑅 𝑀𝑈𝑆𝐼𝐶. You find yourself in their office on the regular lately. You’re not even sure why, half the time; maybe you just need somebody to talk to. Somebody who doesn’t know you like the back of their hand…. Y’know, maybe it’s time that you moved out of your comfort zone and made new friends. 𝐸𝐿𝐸𝑉𝐴𝑇𝑂𝑅 𝑀𝑈𝑆𝐼𝐶 seems like a good choice in that regard.

[champstorymedia]

Behind the Scenes: Inside the Remarkable Transformation of a Local Hospital

Introduction: The transformation of a local hospital is an extraordinary journey that often goes unnoticed by the public. However, behind the scenes, there are countless efforts, innovative strategies, and dedicated healthcare professionals working tirelessly to improve patient care and outcomes. In this article, we will delve into the remarkable transformation of a local hospital, exploring the…

[reasonsforhope]

Article | Paywall Free

"The Food and Drug Administration approved new mRNA coronavirus vaccines Thursday [August 22, 2024], clearing the way for shots manufactured by Pfizer-BioNTech and Moderna to start hitting pharmacy shelves and doctor’s offices within a week.

Health officials encourage annual vaccination against the coronavirus, similar to yearly flu shots. Everyone 6 months and older should receive a new vaccine, the Centers for Disease Control and Prevention recommends.

The FDA has yet to approve an updated vaccine from Novavax, which uses a more conventional vaccine development method but has faced financial challenges.

Our scientific understanding of coronavirus vaccines has evolved since they debuted in late 2020. Here’s what to know about the new vaccines.

Why are there new vaccines?

The coronavirus keeps evolving to overcome our immune defenses, and the shield offered by vaccines weakens over time. That’s why federal health officials want people to get an annual updated coronavirus vaccine designed to target the latest variants. They approve them for release in late summer or early fall to coincide with flu shots that Americans are already used to getting.

The underlying vaccine technology and manufacturing process are the same, but components change to account for how the virus morphs. The new vaccines target the KP.2 variant because most recent covid cases are caused by that strain or closely related ones...

Do the vaccines prevent infection?

You probably know by now that vaccinated people can still get covid. But the shots do offer some protection against infection, just not the kind of protection you get from highly effective vaccines for other diseases such as measles.

The 2023-2024 vaccine provided 54 percent increased protection against symptomatic covid infections, according to a CDC study of people who tested for the coronavirus at pharmacies during the first four months after that year’s shot was released...

A nasal vaccine could be better at stopping infections outright by increasing immunity where they take hold, and one is being studied in a trial sponsored by the National Institutes of Health.

If you really want to dodge covid, don’t rely on the vaccine alone and take other precautions such as masking or avoiding crowds...

Do the vaccines help prevent transmission?

You may remember from early coverage of coronavirus vaccines that it was unclear whether shots would reduce transmission. Now, scientists say the answer is yes — even if you’re actively shedding virus.

That’s because the vaccine creates antibodies that reduce the amount of virus entering your cells, limiting how much the virus can replicate and make you even sicker. When vaccination prevents symptoms such as coughing and sneezing, people expel fewer respiratory droplets carrying the virus. When it reduces the viral load in an infected person, people become less contagious.

That’s why Peter Hotez, a physician and co-director of the Texas Children’s Hospital Center for Vaccine Development, said he feels more comfortable in a crowded medical conference, where attendees are probably up to date on their vaccines, than in a crowded airport.

“By having so many vaccinated people, it’s decreasing the number of days you are shedding virus if you get a breakthrough infection, and it decreases the amount of virus you are shedding,” Hotez said.

Do vaccines prevent long covid?

While the threat of acute serious respiratory covid disease has faded, developing the lingering symptoms of “long covid” remains a concern for people who have had even mild cases. The CDC says vaccination is the “best available tool” to reduce the risk of long covid in children and adults. The exact mechanism is unclear, but experts theorize that vaccines help by reducing the severity of illness, which is a major risk factor for long covid.

When is the best time to get a new coronavirus vaccine?

It depends on your circumstances, including risk factors for severe disease, when you were last infected or vaccinated, and plans for the months ahead. It’s best to talk these issues through with a doctor.

If you are at high risk and have not recently been vaccinated or infected, you may want to get a shot as soon as possible while cases remain high. The summer wave has shown signs of peaking, but cases can still be elevated and take weeks to return to low levels. It’s hard to predict when a winter wave will begin....

Where do I find vaccines?

CVS said its expects to start administering them within days, and Walgreens said that it would start scheduling appointments to receive shots after Sept. 6 and that customers can walk in before then.

Availability at doctor’s offices might take longer. Finding shots for infants and toddlers could be more difficult because many pharmacies do not administer them and not every pediatrician’s office will stock them given low demand and limited storage space.

This year’s updated coronavirus vaccines are supposed to have a longer shelf life, which eases the financial pressures of stocking them.

The CDC plans to relaunch its vaccine locator when the new vaccines are widely available, and similar services are offered by Moderna and Pfizer."

-via The Washington Post, August 22, 2024

[eliaskahtri]

Another New Beginning || Elias Solo

TIMING: Late September

LOCATION: California

PARTIES: Elias

SUMMARY: A lot has happened since Elias left, including psychiatric care and a scientific breakthrough.

CONTENT WARNINGS: None

Having a mild case of fame became Elias’s second worst nightmare. His first worst nightmare was the fact that he had seen things he should have, which defied explanation and science. He had run away from his problems as quickly as he could, leaving everything and everyone he had met in the dust as his car drove out of the city limits of Wicked’s Rest. 

He hadn’t talked to Regan before he left and hadn’t resigned formally. Hadn’t even said goodbye. 

All he had done was leave a note for Gael that just said, “I’m not safe here anymore.” and left it at that. 

He had packed up everything and vanished as if he hadn’t existed there in the first place. He had received messages from both of them, asking where he had gone. He never opened them. 

Instead, he sought out a therapist for his delusions and hallucinations. 

He had been put on three different medications and received extensive talk therapy to deal with his symptoms. It still felt wrong, as if something wasn’t quite right. He knew what he saw, and it had been real. It was real, and now he was being told he suffered hallucinations. His therapist had explained it away by saying he likely suffered a psychotic episode from his high stress with work and seeing someone get killed in front of him. “Some people aren’t equipped to handle these things,” she told him. 

“But it felt so real,” he had responded, to which she simply shrugged her shoulders and responded with “hallucinations can feel very real. That’s why they’re so scary when we experience them.” 

After that, He accepted this as an explanation and began to go back to work. He returned to his job at the local hospital, continuing to work on the prosthetic he had abandoned when he’d moved to Maine.

___

Lisa Peters had sustained nerve damage that had left her ability to flex and use her hand somewhat difficult. She had learned to live with it but would occasionally pursue studies looking for people that fit her description. When she had gotten the offer to be a test subject for a new unreleased prosthetic, she was curious. She was even more curious when they made her sign NDAs and go through extensive interviewing. That’s where she met Dr. Garcia, a middle-aged woman who was, together with the device's creator, hooking up the exoskeleton to her arm. They had explained how it worked, but much of the scientific and medical jargon had gone through one ear and out the other. All she knew was that if this worked, she would regain the ability to use her hand again. It was almost too good to be true. 

He had done it. Elias Kahtri had successfully created a robotic exoskeleton for someone with nerve damage in their hand and arm. All the late-night hours, the mental breakdowns, and running away from responsibility for a time had finally paid off. He had just created a cybernetic prosthetic that would change not only his life but the lives of those who had sustained injuries that had left a limb immobile due to extensive nerve damage. Dr. Ericka Garcia clapped him on the back, and he heard cheering and excitement around him, but he was frozen in place, expressionless and in shock. “Snap out of it, Kahtri!” The doctor spoke to him, shaking his shoulders. “You did it!” 

He did do it, didn’t he? Elias slowly nodded his head, a smile creeping over his face. He did it.

A few weeks later, the news had gone public. Suddenly, everyone and their mother was inundating his phone and email with inquiries about the device he made and when it would be available for the general public. It was overwhelming. All the attention he was getting was beginning to get to him. He had never wanted this. He stayed up late as his phone continued to go off in the darkness of his apartment, face buried in his hands. He was happy about what this meant for those who needed it but absolutely terrified about what it meant for him.

He hired an assistant to help him deal with the sudden influx that fame in the scientific community had brought him. Naya Rana was a twenty-six-year-old, bright-eyed woman who easily fielded questions and interview opportunities. She had been a life-saver. Suddenly, he was going on interviews and news channels to talk about what he had made. Everyone was excited about what this meant; he only wanted a nap. 

Naya forwarded him an email one day that read; 

“Mr. Elias Kahtri, 

We would like to schedule an interview to review your research and offer you an opportunity to work with us out of Wicked’s Rest General Hospital. We look forward to hearing from you to discuss this opportunity further.

Dr. Olivia Patel, MD

Researcher at Wickeds Rest General Hospital”

Naya had bounded over to him that day after sending the email to him, a bright smile on her face. “My family is from Wicked’s Rest!” She explained, stumbling over her words as she explained that she missed her family and would love to be close to them again. 

Elias had refused at first. He had lived there for a brief stint and abandoned it. What would the people he had met say when he suddenly returned? He couldn’t face them. Still, he kept thinking about it. After a week, he randomly blurted out, “Let’s go to Wicked’s Rest.” Naya had been shocked when he said it but slowly nodded her head. “Alright. I can reach out to them and get more information about it.”

Now, there he was. Standing in the middle of a pre-furnished apartment that reflected none of his personality. It was like a ghost lived there instead of the fun-loving individual he once was. He was empty and needed a chance to rediscover himself—one step at a time.

[texasdreamer01]

So I'm pretty sure that I found the Time article in question, which I will provide a link to here, and also provide the full transcript of the article below (with link to the study in question both hyperlinked in-text and provided again below the article transcript). If you are paywalled, I recommend reading this article on Firefox and toggling for reader view.

If there is any field of science that understands the doctrine of unintended consequences, it’s medicine. We rely on antibiotics to wipe out infections, and in the process breed a class of superbugs resistant to the drugs. We develop powerful medications that can control chronic pain, and in the U.S., have a nationwide addiction crisis to show for that breakthrough. Now, it appears, we can add asthma control to the list pharmaceutical blowbacks we didn’t see coming. According to a new study published in BMJ Open, the familiar lightweight, pocket-sized aerosolized inhalers that make breathing easier for so many of the 235 million people worldwide who suffer from asthma may be choking the planet on a powerful greenhouse gas they release in the process. The study, led by Dr. Alexander JK Wilkinson, a respiratory specialist with Britain’s National Health Service, focused on the 4.67 million people diagnosed with asthma in the United Kingdom, but it has implications for treatment worldwide, including in the U.S., where 22.6 million people (6.1 million of them children) are afflicted with the condition. The researcher compared the greenhouse gas emissions of aerosol pumps—known as metered dose inhalers (MDI)—with dry powder inhalers (DPI), which are shaped something like a hockey puck and are activated simply by inhaling. The two weren’t even close. The problem with MDIs is not carbon dioxide (the most common greenhouse gas), but rather two types of hydrofluoroalkane (HFA) gas, which represents a far smaller share of greenhouse emissions, but a much more powerful one. Even the least polluting inhaler was found to emit HFAs at levels equal to up to 10 kg (22 lbs.) of carbon dioxide into the air over the course of its 200-puff lifetime. The worst emitted the equivalent of more than 36 kg (79 lbs) of CO2.

Dry powder inhalers, by comparison, use no HFA propellants at all. To the extent that they have any carbon footprint, it’s mostly from their manufacture and disposal, and the numbers are comparatively small—from 1.5 kg to 6 kg (3.3 lbs to 13 lbs) CO2 equivalent depending on brand. In the U.K., MDIs represent about 70% of all inhaler prescriptions and the researchers estimate they are responsible for releasing the equivalent of 635,000 metric tons of carbon dioxide each year. If just 10% of those patients switched to DPIs, the equivalent of 58,000 metric tons of CO2 could be kept out of the atmosphere. That, Britain’s Sky News pointed out, is the same carbon footprint as 180,000 gas-powered cars driving making the round-trip journey between London and Edinburgh—about 1,300 km (or approximately 800 miles) each.

What makes such a switchover especially important, the study argues, is that many of the people who are hurt most by all this MDI outgassing are the very people the inhalers are designed to help. “Climate change is a huge and present threat to health which will disproportionately impact the poorest and most vulnerable people on the planet,” the researchers wrote, “including people with pre-existing lung disease.” Across the rest of Europe, less than 50% of inhalers prescribed are MDIs and in Scandinavia it’s barely 10%. The difference, in most cases, is less about pharmaceutical efficacy than simply local medical custom and practice. The authors are not calling for a blanket elimination of MDIs. Dry powder inhalers require patients to have at least enough lung strength to draw in the medication, and many do not. For them, the forced puff of an MDI is the only way to administer the drug. “We recognize the need to protect the environment,” said Jesica Kirby, head of health advice for the advocacy group Asthma UK, in a statement responding to the study, “but it’s critically important that people with asthma receive the medicines they need to stay well and avoid a life-threatening asthma attack.” As with so many things medical, the right solution is all about finding the proper balance between cost and benefits. In the case of asthma, the benefit of dialing back the aerosols and turning to alternatives whenever possible can accrue to not just individual patients, but the planet at large. Editor’s note, Nov. 7 The original headline on this story has been updated to clarify that it is one commonly used type of inhaler—not all inhalers—that emits significant greenhouse gases. Correction, Nov. 9 An earlier version of this story misstated the greenhouse gas in the inhalers. It is hydrofluoroalkane, not methane.

Note: Article posted on November 5, 2019.

Study citation:

Wilkinson AJK, Braggins R, Steinbach I, et al. Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England. BMJ Open 2019;9:e028763. doi:10.1136/bmjopen-2018-028763

Link to study (PDF): https://bmjopen.bmj.com/content/bmjopen/9/10/e028763.full.pdf

The propellants in question are made of hydrofluoroalkane, an organofluorine compound (Wikipedia). Some more familiar ones in this category, as the study refers to, would be CFCs and HCFCs (hydrochlorofluorocarbon) - which would be greenhouse gases, as well as PFOS (see: Scotchguard) and PFOA (see: Teflon).

PFOS and PFOA are in particular noted as carcinogens (American Cancer Society), whereas CFCs and HCFCs are noted as ozone-depleting chemicals (see Wikipedia link in previous paragraph).

Some additional research, for the curious:

Hays, Hannah L., and Henry Spiller. "Fluoropolymer-associated illness." Clinical Toxicology 52, no. 8 (2014): 848-855. https://www.tandfonline.com/doi/abs/10.3109/15563650.2014.946610

Levin, P. D., D. Levin, and A. Avidan. "Medical aerosol propellant interference with infrared anaesthetic gas monitors." British journal of anaesthesia 92, no. 6 (2004): 865-869. https://www.researchgate.net/publication/8583173_Medical_aerosol_propellant_interference_with_infrared_anaesthetic_gas_monitors

Savoca, Dario, and Andrea Pace. "Bioaccumulation, biodistribution, toxicology and biomonitoring of organofluorine compounds in aquatic organisms." International Journal of Molecular Sciences 22, no. 12 (2021): 6276. https://www.mdpi.com/1422-0067/22/12/6276

Vervaet, Chris, and Peter R. Byron. "Drug–surfactant–propellant interactions in HFA-formulations." International journal of pharmaceutics 186, no. 1 (1999): 13-30. https://www.sciencedirect.com/science/article/abs/pii/S0378517399001349

Zhu, Bing, Daniela Traini, and Paul Young. "Aerosol particle generation from solution-based pressurized metered dose inhalers: a technical overview of parameters that influence respiratory deposition." Pharmaceutical Development and Technology 20, no. 8 (2015): 897-910. https://www.researchgate.net/publication/266028254_Aerosol_particle_generation_from_solution-based_pressurized_metered_dose_inhalers_A_technical_overview_of_parameters_that_influence_respiratory_deposition

TL;DR

Acknowledging that chemical pollutants are a component in inhalers is not eco-ableism.

Acknowledging that perhaps these chemicals should be considered for replacement with less-pollutive versions is not eco-ableism.

The fact that there are other avenues of pollution currently in the world does not mean medical devices should not be considered for improvement on design.

So many people wouldn’t have asthma in the first place if it wasn’t for these corporations…Shifting blame from actual culprits to people with asthma (and people who can’t help but use plastic straws at that) is peak capitalism.

[thetechpulsz]

Neurotech Wearables: Top 5 Gadgets Enhancing Mental Health in 2025

Why Neurotech Wearables Are 2025’s Mental Health Game-Changers

By 2025, 1 in 4 adults will use neurotech wearables to manage stress, anxiety, and sleep disorders (Global Wellness Institute). These devices combine EEG, AI, and biometric tracking to offer real-time mental health support—no prescription needed. Here’s how they work, which ones to buy, and their clinical validation.

Top 5 Neurotech Wearables of 2025

1. Muse S (Gen 4): Stress & Sleep Optimization Tech: EEG sensors + AI analyze brainwaves to guide meditation and improve sleep quality. Features: - Stress Score: Rates stress levels (1–100) in real time. - Sleep Tracking: Detects REM cycles and provides audio cues for deep sleep. Clinical Backing: 80% users reported lower cortisol levels after 4 weeks (UC Berkeley Study). Price: $299. 2. Neurable FocusBand: ADHD Management Innovation: Non-invasive EEG headband gamifies focus training for ADHD patients. Use Case: Kids complete math puzzles while the band rewards sustained focus with in-app points. Trial Results: 40% improvement in attention spans (NIH-funded study). Price: 249(subscription:249(subscription:15/month for app). 3. Apollo Neuro 2.0: Anxiety Relief How It Works: Wrist-worn device emits silent vibrations to activate the parasympathetic nervous system. Modes: “Energy,” “Focus,” “Calm.” Case Study: ER nurses reduced burnout symptoms by 35% using “Calm” mode during shifts. Price: $399. 4. SoundMind Earbuds: PTSD & Trauma Support Tech: Uses AI-generated binaural beats and heartbeat sync to reduce flashbacks. App Integration: Tailors soundscapes based on user-reported triggers (e.g., crowds, loud noises). FDA Status: Cleared as a Class II medical device in 2024. Price: $199. 5. Embr Wave 3: Thermal Mood Regulation Breakthrough: Wrist device cools or warms the skin to combat anxiety spikes. Science: Thermal shifts trigger dopamine release, lowering stress within 5 minutes. Partnerships: Used by Cisco and Salesforce in employee wellness programs. Price: $179. Challenges in 2025 - Privacy Risks: 33% of devices lack end-to-end encryption for brainwave data (NeuroRights Report). - Regulation: FDA’s Neurotech Oversight Act mandates clinical trials for mental health claims. - Cost: Most insurance plans don’t cover wearables (out-of-pocket only). How to Integrate Neurotech Wearables - For Consumers: Start with affordable options like Embr Wave 3 ($179). - For Clinicians: Prescribe SoundMind Earbuds as adjunct therapy for PTSD. - For Employers: Partner with Apollo Neuro for bulk corporate discounts. FAQs Q: Are neurotech wearables safe? A: Yes! Non-invasive devices like Muse and Apollo have no reported side effects (FDA database). Q: Do they replace therapy? A: No—they complement treatment. Always consult a mental health professional. Q: Can kids use them? A: FocusBand is FDA-approved for ages 8+, but parental supervision is advised. Case Study: ZenTech Solutions Employee Wellness Program - Challenge: High burnout rates among remote developers. - Solution: Provided Muse S bands and Apollo Neuro devices to 200 employees. - Result: - 45% drop in burnout symptoms. - 30% increase in productivity (self-reported). Final Thoughts Neurotech wearables are democratizing mental health care—making it proactive, personalized, and portable. Early adopters will gain a competitive edge in wellness-driven industries. Read the full article

[stellaphlebotomist]

Open Your Career Potential: Top Phlebotomy Training Programs in Canada

Unlock Yoru Career Potential: top Phlebotomy Training Programs in Canada

Are you ‌considering a career⁢ in healthcare? Phlebotomy ⁤might be the perfect path for you. This essential role involves drawing blood adn preparing samples for laboratory testing, helping to diagnose and treat health conditions. With a growing demand for skilled ‍phlebotomists in Canada, now is the ideal time to explore top phlebotomy‍ training⁣ programs⁣ across the country. In this guide, ⁢we’ll outline the best ⁣options available, the benefits of studying ⁣phlebotomy, and tips for succeeding⁢ in this rewarding field.

Why Choose Phlebotomy?

Phlebotomy is ‍an integral part of the medical community. Here ⁣are ⁢some compelling reasons ⁣to consider this career:

Job Demand: The healthcare industry is expanding, leading⁢ to an increased ⁤need for trained phlebotomists.

Adequate Compensation: Phlebotomists earn⁢ competitive salaries,​ with‌ potential for⁢ pay increases as⁤ you gain experience.

Short Training Period: Phlebotomy programs are typically‍ short-term, ⁤allowing you to enter the workforce quickly.

Career Advancement: with experience, you can ⁣pursue certifications and higher positions within the healthcare field.

Top Phlebotomy ‍Training⁤ Programs in Canada

When ⁣considering‍ your options for phlebotomy training, it’s essential ⁣to ‌choose⁢ a program that offers comprehensive education‍ and practical experience. Here’s a list of some of the top phlebotomy training programs in Canada:

Program Name

Location

Duration

Cost

Centennial college ⁣- Phlebotomy Technician Program

Toronto, ON

8 months

$2,200

American Red Cross – Phlebotomy Training

Vancouver, BC

6 weeks

$1,800

Douglas College ⁢-​ Phlebotomy Technician ‌Program

New Westminster, BC

10 months

$2,500

Fanshawe ⁢College – Phlebotomy Technician Program

London, ON

1 year

$2,900

Algonquin College ⁣- ‌Phlebotomy Technician Program

Ottawa, ON

8 months

$2,400

What to Expect from Phlebotomy Training

Phlebotomy⁣ training programs generally cover the⁢ following topics:

Anatomy and Physiology: Understanding the human body and how blood circulates.

Venipuncture⁣ Techniques: Learning proper techniques for drawing blood.

Safety procedures: ⁤ Understanding how to​ ensure safety for both‍ the patient and the‍ phlebotomist.

Patient Interaction: Developing⁤ skills for communicating effectively with patients.

Benefits of Pursuing a Phlebotomy Certification

Obtaining‍ a phlebotomy certification can lead to various advantages, such as:

Increased ⁣Employability: Employers frequently enough‌ prefer certified phlebotomists, as⁤ it ​demonstrates a commitment to the profession.

Career⁢ Growth: Certifications can open doors to ​advanced positions within healthcare‌ settings.

Networking ⁤Opportunities: ⁤Being part of⁤ professional organizations can connect you with industry ‍experts.

Practical‌ Tips for​ Succeeding in ⁣Phlebotomy

To excel as a phlebotomist, consider the following practical tips:

Practice Regularly: Get as ⁣much hands-on experience as ⁣possible during your training.

Stay Updated: Keep current with⁣ industry standards ​and practices by attending workshops and seminars.

Enhance Communication Skills: Develop strong interpersonal skills to ease ⁤patient anxiety ⁤during procedures.

Case Studies: Success Stories of Phlebotomy Graduates

Many graduates have experienced rewarding‌ careers after completing ⁣their phlebotomy training. Here are‍ a couple ⁤of success ⁣stories:

Maria’s Journey

after⁢ completing the Phlebotomy Technician Program at Centennial College, Maria landed a job‌ at a local hospital. Within one year,her excellent performance secured ⁤her a managerial position overseeing ‌new phlebotomy staff.

David’s breakthrough

David, who trained through the American Red Cross program, ⁣realized his ‍love for patient‌ care while drawing blood. He pursued further education and is now a registered nurse, making‍ a significant impact in‍ patient health.

Getting started: Steps ​to‌ Enroll in a Phlebotomy Program

Here’s how you can kickstart your phlebotomy⁣ career:

Research Programs: Compare various ‌programs based on location, duration, and cost.

Check⁣ Admission Requirements: Ensure you meet the prerequisites for your⁣ chosen program.

Apply⁤ for Financial Aid if Necessary: Look into scholarships and⁣ grants to help fund your education.

Complete Your Training: Fully engage during your program to gain valuable knowledge and‌ skills.

Conclusion

Pursuing a career in phlebotomy can be a fulfilling experience ⁢with‌ numerous opportunities‍ for ‍growth and advancement.By selecting one⁣ of‍ the top phlebotomy training programs in Canada, you’re taking the first step towards unlocking ⁤your career potential. Remember to stay curious, practice⁣ diligently, and ⁣engage ⁢with​ the healthcare community to maximize your ⁢success. It’s time⁢ to embrace ⁢this rewarding‌ career path and make a real difference in⁤ the lives of ⁢patients across ⁣Canada!

For more information on ⁢healthcare⁤ careers and educational opportunities, feel free ⁤to ‌explore​ additional resources ⁤and ⁤programs available in Canada.

https://phlebotomytechnicianprogram.org/open-your-career-potential-top-phlebotomy-training-programs-in-canada/

[hasanhesblogs]

Remivir 100mg (Remdesivir): A Breakthrough in Antiviral Treatment

Remivir 100mg, containing the active ingredient Remdesivir, is an antiviral medication that has gained significant attention for its role in treating severe viral infections, particularly COVID-19. Originally developed to combat Ebola, Remdesivir has shown efficacy against a range of RNA viruses, making it a versatile tool in modern medicine.

How Remivir 100mg Works

Remdesivir, the core component of Remivir 100mg, functions as a nucleotide analog. It integrates into the viral RNA during replication, causing premature termination of the RNA chain. This mechanism effectively halts viral replication, reducing the viral load in the body. By targeting the virus directly, Remivir 100mg helps patients recover faster, especially in cases of severe respiratory infections.

Clinical Applications of Remivir 100mg

Remivir 100mg is primarily used to treat COVID-19 in hospitalized patients. Clinical trials have demonstrated its ability to shorten recovery time and improve outcomes in severe cases. It is administered intravenously under medical supervision, ensuring optimal dosing and monitoring for potential side effects.

Safety and Side Effects

While Remivir 100mg is generally well-tolerated, some patients may experience side effects such as nausea, elevated liver enzymes, or allergic reactions. It is crucial to administer this medication in a controlled environment to manage any adverse effects promptly.

Availability and Accessibility

Remivir 100mg is available through authorized healthcare providers and pharmacies, including Mediaid Pharmacy. Its distribution is tightly regulated to ensure it reaches patients who need it most.

The Role of Remdesivir in Global Health

The COVID-19 pandemic highlighted the importance of antiviral medications like Remdesivir. Its rapid development and deployment underscored the potential of repurposing existing drugs to address emerging health crises. As research continues, Remdesivir may find applications in treating other viral infections, further solidifying its place in modern medicine.

Future Prospects

Ongoing studies are exploring the use of Remivir 100mg in combination with other antiviral therapies. These efforts aim to enhance its efficacy and expand its use beyond COVID-19. With its proven track record, Remdesivir remains a cornerstone in the fight against viral diseases.

Next Session: Tofacinix 11mg (Tofacitinib)

Stay tuned for our next, where we delve into Tofacinix 11mg (Tofacitinib), a revolutionary treatment for autoimmune conditions like rheumatoid arthritis and ulcerative colitis. Discover how this JAK inhibitor works, its clinical benefits, and what makes it a game-changer for patients worldwide.

For more insights, check out these resources:

Wikipedia: Tofacitinib

Quora: How does Tofacitinib work?

Medium: Advances in Autoimmune Treatments

Don’t miss this deep dive into Tofacinix 11mg and its impact on autoimmune therapy. Subscribe to https://mediaidpharmacy.com/ for the latest updates and expert insights!

[lcacommunuty]

H.E.L.P. Apheresis: A Promising Treatment for Long COVID Patients

Understanding Long COVID and Its Devastating Impact

Long COVID has emerged as a severe, lingering condition affecting millions of people worldwide. Many individuals who recover from the acute phase of COVID-19 continue to experience persistent symptoms such as fatigue, brain fog, shortness of breath, chest pain, joint pain, and autonomic dysfunction. These debilitating effects can last months or even years, severely impacting daily life and productivity.

Despite various treatment attempts, many patients struggle to find effective relief. This is where H.E.L.P. Apheresis is gaining attention as a potential breakthrough therapy for Long COVID apheresis.

What is H.E.L.P. Apheresis?

H.E.L.P. Apheresis is an advanced blood filtration treatment initially developed for cardiovascular diseases, hyperlipidemia, and autoimmune conditions. This process removes harmful substances from the blood, including:

Fibrinogen and Coagulation Factors – Reducing microclots and improving blood flow

Inflammatory Cytokines – Lowering chronic inflammation levels

LDL Cholesterol and Lipoproteins – Enhancing cardiovascular health

Autoantibodies – Beneficial for immune system regulation

Recent studies and patient reports suggest that H.E.L.P. Apheresis for Long COVID may help alleviate symptoms by reducing microclots, improving blood circulation, and lowering inflammation—key factors believed to drive Long COVID.

Why Microclots Play a Key Role in Long COVID

One of the leading theories behind Long COVID symptoms is the formation of microclots, which can impair oxygen delivery and lead to persistent fatigue, cognitive dysfunction, and organ damage. Research indicates that many Long COVID patients have elevated fibrinogen levels and dysfunctional blood flow, which may contribute to their prolonged symptoms.

H.E.L.P. Apheresis effectively removes these microclots and reduces blood viscosity, leading to better oxygen transport, improved circulation, and reduced systemic inflammation. Patients undergoing this treatment often report enhanced energy levels, cognitive clarity, and a significant reduction in Long COVID symptoms.

The Process of H.E.L.P. Apheresis for Long COVID Patients

The H.E.L.P. Apheresis procedure is a sophisticated blood purification process performed in specialized medical centers. The treatment involves:

Blood Withdrawal – A catheter extracts blood from the patient.

Filtration & Separation – Blood components are separated, and excess fibrinogen, LDL cholesterol, inflammatory molecules, and microclots are removed.

Blood Reinfusion – The purified blood is returned to the body, enhancing circulation and oxygenation.

Each session lasts 2–3 hours, and most patients require multiple sessions for optimal results. Some patients notice improvements after just a few treatments, while others may need several weeks to experience significant benefits.

Patient Experiences and Success Stories

Many Long COVID sufferers who have undergone H.E.L.P. Apheresis report remarkable improvements in symptoms. These include:

Reduced fatigue and increased energy levels

Improved brain function, focus, and memory

Less shortness of breath and improved oxygenation

Relief from chest pain, muscle weakness, and autonomic dysfunction

Patients who were previously unable to work or carry out daily activities have regained their quality of life after undergoing this treatment.

Scientific Research Supporting H.E.L.P. Apheresis for Long COVID

While clinical trials for Long COVID apheresis are still emerging, existing research on blood filtration and microclot removal strongly supports the benefits of this therapy. Studies on post-viral syndromes, autoimmune disorders, and hyperlipidemia indicate that H.E.L.P. Apheresis significantly improves vascular health, reduces inflammation, and enhances blood flow.

Recent case studies of Long COVID patients undergoing apheresis have shown promising results, with measurable improvements in biomarkers of inflammation, clotting factors, and endothelial function.

Who Can Benefit from H.E.L.P. Apheresis?

This treatment is particularly beneficial for Long COVID patients who:

🔹 Experience persistent fatigue, brain fog, and neurological issues 🔹 Have elevated fibrinogen levels or clotting abnormalities 🔹 Show signs of endothelial dysfunction and poor circulation 🔹 Have tried other treatments without success

If you are struggling with Long COVID symptoms, it is essential to consult a specialist to determine if H.E.L.P. Apheresis is a suitable option for you.

Join the Long COVID Apheresis (LCA) Community for Support and Information

Navigating Long COVID recovery can be overwhelming, but you are not alone. The LCA Community (Long COVID Apheresis) is a support network for patients exploring H.E.L.P. Apheresis and other advanced treatment options.

By joining, you gain access to:

Expert insights and medical research updates

Real patient experiences and success stories

Ongoing discussions about the latest Long COVID treatments

A supportive community of individuals on the same journey

Final Thoughts: Is H.E.L.P. Apheresis the Future of Long COVID Treatment?

While H.E.L.P. Apheresis for Long COVID is still gaining traction, its potential to remove microclots, reduce inflammation, and improve circulation makes it one of the most promising treatments. After undergoing this therapy, Many patients regained their energy, cognitive function, and overall health.

Exploring H.E.L.P. Apheresis could be a crucial step toward recovery if you are searching for an effective Long COVID treatment. Connect with the LCA Community today to learn more and stay informed about the latest breakthroughs in Long COVID apheresis treatment.